• WELL Health Technologies' management commentary reported a CAD 135.51 million net loss for third-quarter 2026, versus a CAD 2.65 million year-earlier loss.
• Revenue rose to CAD 407.4 million from CAD 364.6 million, with Canadian patient services generating higher sales.
• Impairment charges reached CAD 67.49 million, including CAD 39.8 million against HEALWELL goodwill.
• Management attributed HEALWELL's impairment to below-forecast revenue growth, a sustained share-price decline and higher market discount rates.
• Net finance costs increased to CAD 43.65 million; WELLSTAR's reverse takeover listing expense and transaction costs totaled CAD 24.45 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. WELL Health Technologies Corp. published the original content used to generate this news brief on November 09, 2026, and is solely responsible for the information contained therein.